Perella Weinberg Partners Capital Management’s Gilead Sciences GILD Stock Holding History

Perella Weinberg Partners Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-12,674	Closed	-$793K	–	211
2018 Q4	$793K	Buy	+12,674	New	+$886K	0.05%	175
2018 Q2	–	Sell	-35,790	Closed	-$2.7M	–	206
2018 Q1	$2.7M	Buy	+35,790	New	+$2.85M	0.12%	143
2017 Q4	–	Sell	-6,928	Closed	-$561	–	147
2017 Q3	$561	Sell	6,928 -6,028	-47%	-$461K	0.05%	128
2017 Q2	$917K	Buy	12,956 +6,028	+87%	+$401K	0.11%	136
2017 Q1	$471K	Buy	+6,928	New	+$487K	0.08%	121
2014 Q2	–	Sell	-25,000	Closed	-$1.77M	–	144
2014 Q1	$1.77M	Buy	+25,000	New	+$1.96M	0.23%	81
2013 Q3	–	Sell	-206,680	Closed	-$10.6M	–	162
2013 Q2	$10.6M	Buy	+206,680	New	+$10.8M	0.72%	42

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Perella Weinberg Partners Capital Management's GILD Position: Q1 2019 in Review

Perella Weinberg Partners Capital Management sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 12,674 shares — an estimated $793K sold.

Perella Weinberg Partners Capital Management first reported a position in GILD in Q2 2013 and held it in 7 quarters. The position peaked at $10.6M in Q2 2013. 1,492 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

Perella Weinberg Partners Capital Management reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
Perella Weinberg Partners Capital Management sold 12,674 Gilead Sciences shares in Q1 2019, an estimated $793K.
Perella Weinberg Partners Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 7 quarters.
Perella Weinberg Partners Capital Management's Gilead Sciences position peaked at $10.6M in Q2 2013.
1,492 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Perella Weinberg Partners Capital Management's 13F filing for Q1 2019, filed 6 May 2019.